These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 11366888

  • 21. Supplement fix for nelfinavir-related diarrhea.
    TreatmentUpdate; 2002 Nov; 14(8):8. PubMed ID: 12501830
    [No Abstract] [Full Text] [Related]

  • 22. Nelfinavir: fourth protease inhibitor approved.
    Crit Path AIDS Proj; 1997 Nov; (No 32):31-2. PubMed ID: 11364442
    [Abstract] [Full Text] [Related]

  • 23. [Holding option open for subsequent treatment. Beginning therapy with a protease inhibitor].
    MMW Fortschr Med; 2000 Nov; 142(3 Suppl):8-9. PubMed ID: 10893948
    [No Abstract] [Full Text] [Related]

  • 24. Efficacy and safety of twice-daily versus three-times daily saquinavir soft gelatin capsules as part of triple combination therapy for HIV-1 infection.
    Wheat LJ, Farthing C, Cohen C, Pierone G, Lalezari J, Pilson RS, Siemon-Hryczyk P, TIDBID (NR15520/M61018) study team.
    Antivir Ther; 2002 Sep; 7(3):199-209. PubMed ID: 12487388
    [Abstract] [Full Text] [Related]

  • 25. Nelfinavir (Viracept) moves up the ranks.
    Grodeck B.
    Posit Aware; 1997 Sep; 8(2):16-7. PubMed ID: 11364452
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Effect of antiretroviral triple combinations including the protease inhibitor nelfinavir in heavily pretreated children with HIV-1 infection.
    Hoffmann F, Funk M, Linde R, Notheis G, Petropoulou T, Eberle J, Gürtler L, Belohradsky BH, Wintergerst U.
    Eur J Med Res; 2002 Jul 24; 7(7):330-4. PubMed ID: 12176683
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Fourth protease inhibitor hits the market.
    AIDS Alert; 1997 May 24; 12(5):59-60. PubMed ID: 11364224
    [Abstract] [Full Text] [Related]

  • 31. Viracept and irregular heartbeat warning.
    Fornataro K, Jefferys R.
    Body Posit; 1999 Oct 24; 12(10):10, 12. PubMed ID: 11366874
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. A randomized clinical trial comparing nelfinavir or nevirapine associated to zidovudine/lamivudine in HIV-infected naive patients (the Combine Study).
    Podzamczer D, Ferrer E, Consiglio E, Gatell JM, Perez P, Perez JL, Luna E, González A, Pedrol E, Lozano L, Ocaña I, Llibre JM, Casiró A, Aranda M, Barrufet P, Martínez-Lacasa J, Miró JM, Badía X, Casado A, Lupo S, Cahn P, Maños M, Estela J.
    Antivir Ther; 2002 Jun 24; 7(2):81-90. PubMed ID: 12212928
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Nelfinavir pharmacokinetics in HIV-infected children: a comparison of twice daily and three times daily dosing.
    Schuster T, Linde R, Wintergerst U, Funk MB, Kurowski M, Kreuz W, Hofmann D.
    AIDS; 2000 Jul 07; 14(10):1466-8. PubMed ID: 10930171
    [No Abstract] [Full Text] [Related]

  • 36. The application of accelerator mass spectrometry to absolute bioavailability studies in humans: simultaneous administration of an intravenous microdose of 14C-nelfinavir mesylate solution and oral nelfinavir to healthy volunteers.
    Sarapa N, Hsyu PH, Lappin G, Garner RC.
    J Clin Pharmacol; 2005 Oct 07; 45(10):1198-205. PubMed ID: 16172185
    [Abstract] [Full Text] [Related]

  • 37. Nelfinavir plasma levels under twice-daily and three-times-daily regimens: high interpatient and low intrapatient variability.
    Marzolini C, Buclin T, Decosterd LA, Biollaz J, Telenti A.
    Ther Drug Monit; 2001 Aug 07; 23(4):394-8. PubMed ID: 11477322
    [Abstract] [Full Text] [Related]

  • 38. Report from the 4th International Workshop on Clinical Pharmacology of HIV Therapy. Does Roche's nelfinavir cause less diarrhea?
    TreatmentUpdate; 2003 Aug 07; 15(3):7. PubMed ID: 17216849
    [No Abstract] [Full Text] [Related]

  • 39. Pharmacokinetics of nelfinavir in children: influencing factors and dose implications.
    Bergshoeff AS, Fraaij PL, van Rossum AM, Wolfs TF, Geelen SP, de Groot R, Burger DM.
    Antivir Ther; 2003 Jun 07; 8(3):215-22. PubMed ID: 12924538
    [Abstract] [Full Text] [Related]

  • 40. Antiretroviral treatment. HIV infection in adults: better-defined first-line treatment.
    Prescrire Int; 2004 Aug 07; 13(72):144-50. PubMed ID: 15532140
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.